Axa’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-16,700
| Closed | -$775K | – | 1271 |
|
2020
Q4 | $775K | Hold |
16,700
| – | – | ﹤0.01% | 1013 |
|
2020
Q3 | $550K | Hold |
16,700
| – | – | ﹤0.01% | 1023 |
|
2020
Q2 | $458K | Sell |
16,700
-25,400
| -60% | -$697K | ﹤0.01% | 1075 |
|
2020
Q1 | $1.26M | Buy |
+42,100
| New | +$1.26M | 0.01% | 819 |
|
2019
Q1 | – | Sell |
-85,795
| Closed | -$759K | – | 1346 |
|
2018
Q4 | $759K | Sell |
85,795
-17,400
| -17% | -$154K | ﹤0.01% | 1014 |
|
2018
Q3 | $1.16M | Hold |
103,195
| – | – | ﹤0.01% | 1005 |
|
2018
Q2 | $1.32M | Buy |
103,195
+18,492
| +22% | +$237K | 0.01% | 943 |
|
2018
Q1 | $1.43M | Sell |
84,703
-584,272
| -87% | -$9.87M | 0.01% | 927 |
|
2017
Q4 | $5.35M | Sell |
668,975
-612
| -0.1% | -$4.9K | 0.02% | 630 |
|
2017
Q3 | $5.19M | Sell |
669,587
-9,180
| -1% | -$71.1K | 0.02% | 617 |
|
2017
Q2 | $4.99M | Sell |
678,767
-18,115
| -3% | -$133K | 0.02% | 607 |
|
2017
Q1 | $5.19M | Buy |
696,882
+364
| +0.1% | +$2.71K | 0.02% | 588 |
|
2016
Q4 | $4.84M | Buy |
696,518
+13,013
| +2% | +$90.4K | 0.02% | 590 |
|
2016
Q3 | $5.63M | Sell |
683,505
-84,256
| -11% | -$693K | 0.02% | 543 |
|
2016
Q2 | $6.22M | Sell |
767,761
-27,371
| -3% | -$222K | 0.03% | 519 |
|
2016
Q1 | $4.04M | Buy |
+795,132
| New | +$4.04M | 0.02% | 612 |
|